19,790.00
-100(-0.50%)
Currency In KRW
Address
121 Wausan Ro
Seoul, 04054
Korea, Republic of
Phone
82 2 3140 0700
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
586
First IPO Date
September 29, 2005
| Name | Title | Pay | Year Born |
| Ji-hyeon Choi | Chief Executive Officer & Director | 0 | N/A |
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.